1. Home
  2. FLUX vs GDTC Comparison

FLUX vs GDTC Comparison

Compare FLUX & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flux Power Holdings Inc.

FLUX

Flux Power Holdings Inc.

BUY

Current Price

$0.41

Market Cap

11.9M

Sector

Miscellaneous

ML Signal

BUY

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

N/A

Current Price

$0.88

Market Cap

10.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FLUX
GDTC
Founded
N/A
2018
Country
United States
Singapore
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.9M
10.4M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
FLUX
GDTC
Price
$0.41
$0.88
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $4.53
N/A
AVG Volume (30 Days)
★ 503.9K
19.5K
Earning Date
11-12-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 5.00
N/A
EPS
N/A
★ N/A
Revenue
★ $9,317,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$85.96
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 126.25
N/A
52 Week Low
$0.40
$0.68
52 Week High
$7.55
$3.68

Technical Indicators

Market Signals
Indicator
FLUX
GDTC
Relative Strength Index (RSI) 36.77 46.00
Support Level $0.40 $0.73
Resistance Level $0.55 $1.07
Average True Range (ATR) 0.05 0.11
MACD -0.00 -0.01
Stochastic Oscillator 9.43 40.00

Price Performance

Historical Comparison
FLUX
GDTC

About FLUX Flux Power Holdings Inc.

Flux Power Holdings Inc. designs, develops, manufactures, and sells a portfolio of lithium-ion energy storage solutions for the electrification of a range of industrial and commercial sectors, which include material handling, airport ground support equipment (GSE), and stationary energy storage. It offers a high-power battery cell management system(BMS). The BMS serves as the brain of the energy storage solution, managing cell balancing, charging, discharging, monitoring, and communication between the pack and the forklift. The company's product portfolio includes Battery Technology and Energy Management solutions.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: